Portfolio company
Earendil Labs
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops an artificial intelligence platform to discover and design biologic medicines for pharmaceutical companies and patients with autoimmune diseases and cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
Epana Bio
This company develops precision T-cell engagers and biologics using artificial intelligence and genomics to treat patients with autoimmune diseases.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
Metaphore Biotechnologies
This biotechnology company develops an artificial intelligence platform to design functional antibody medicines for pharmaceutical partners and patients with autoimmune, metabolic or oncology conditions.
Auron Therapeutics
This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.
Absci
This biopharmaceutical company uses generative artificial intelligence to design and develop biologic medicines for pharmaceutical partners and clinical patients.
Harmonic Discovery
The company develops a machine learning platform to design multi-targeted kinase therapeutics for pharmaceutical firms and healthcare providers treating cancer and autoimmune diseases.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
